Matthew Nelson

Matthew Nelson currently serves as the VP of Financial Planning and Analysis at Orbital Therapeutics since July 2023. Prior to this role, Matthew held the position of VP of Finance at Finch Therapeutics from December 2019 to May 2023, where responsibilities included budgeting and valuation. Matthew's earlier experience includes a Senior Director role in Financial Planning & Analysis at both Finch Therapeutics and Casebia Therapeutics, as well as director-level roles at Casebia Therapeutics and Inotek Pharmaceuticals Corporation, focusing on budgeting and workforce planning. Matthew holds an MBA from Curry College and a BSBA in Accounting and Computer Information Systems from Stonehill College.